The connection between pulmonary embolism and chronic thromboembolic pulmonary hypertension: research session at the American Thoracic Society 2016 Meeting

Por Morris, Timothy
Publicado no J Thorac Dis (2016)

Removal of an apex predator initiates a trophic cascade that extends from herbivores to vegetation and the soil nutrient pool

Por Morris, Timothy, Letnic, Mike
Publicado no Proc Biol Sci (2017)

Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolated from the Eye

Por Hesje, Christine K, Sanfilippo, Christine M, Haas, Wolfgang, Morris, Timothy W
Publicado em 2011

Contribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones

Por Haas, Wolfgang, Sanfilippo, Christine M, Hesje, Christine K, Morris, Timothy W
Publicado em 2013

The Safety of Besifloxacin Ophthalmic Suspension 0.6 % Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis

Por Malhotra, Ranjan, Ackerman, Stacey, Gearinger, Lynne S., Morris, Timothy W., Allaire, Catherine
Publicado em 2013

Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis

Por Comstock, Timothy L, Karpecki, Paul M, Morris, Timothy W, Zhang, Jin-Zhong
Publicado em 2010

Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae

Por Haas, Wolfgang, Pillar, Chris M., Hesje, Christine K., Sanfilippo, Christine M., Morris, Timothy W.
Publicado em 2010

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility prof...

Por Haas, Wolfgang, Gearinger, Lynne S, Usner, Dale W, DeCory, Heleen H, Morris, Timothy W
Publicado em 2011

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections

Por Silverstein, Bruce E, Morris, Timothy W, Gearinger, Lynne S, DeCory, Heleen H, Comstock, Timothy L
Publicado em 2012

Structural Insights into Fibrinogen Dynamics Using Amide Hydrogen/Deuterium Exchange Mass Spectrometry

Por Marsh, James J., Guan, Henry S., Li, Sheng, Chiles, Peter G., Tran, Danny, Morris, Timothy A.
Publicado em 2013

Acanthamoeba encystment: multifactorial effects of buffers, biocides, and demulcents present in contact lens care solutions

Por Kovacs, Christopher J, Lynch, Shawn C, Rah, Marjorie J, Millard, Kimberly A, Morris, Timothy W
Publicado no Clin Ophthalmol (2015)

Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria

Por Haas, Wolfgang, Pillar, Chris M., Zurenko, Gary E., Lee, Jacqueline C., Brunner, Lynne S., Morris, Timothy W.
Publicado em 2009

Fibrin Derived from Patients with Chronic Thromboembolic Pulmonary Hypertension Is Resistant to Lysis

Por Morris, Timothy A., Marsh, James J., Chiles, Peter G., Auger, William R., Fedullo, Peter F., Woods, Virgil L.
Publicado em 2006

Amphipathic polymer-mediated uptake of trehalose for dimethyl sulfoxide-free human cell cryopreservation()()

Por Sharp, Duncan M.C., Picken, Andrew, Morris, Timothy J., Hewitt, Christopher J., Coopman, Karen, Slater, Nigel K.H.
Publicado em 2013

Chronic exposure to fibrin and fibrinogen differentially regulates intracellular Ca(2+) in human pulmonary arterial smooth muscle and endothelial cells

Por Firth, Amy L., Yau, Jocelyn, White, Amanda, Chiles, Peter G., Marsh, James J., Morris, Timothy A., Yuan, Jason X.-J.
Publicado em 2009

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes

Por Morris, Timothy W, Gearinger, Lynne S, Usner, Dale W, Paterno, Michael R, DeCory, Heleen H, Comstock, Timothy L, Haas, Wolfgang
Publicado em 2011

Staphylococcus aureus Mutants Isolated via Exposure to Nonfluorinated Quinolones: Detection of Known and Unique Mutations

Por Roychoudhury, Siddhartha, Twinem, Tracy L., Makin, Kelly M., Nienaber, Mark A., Li, Chuiying, Morris, Timothy W., Ledoussal, Benoit, Catrenich, Carl E.
Publicado em 2001

A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: childhood outcomes at 5 years

Por Marlow, Neil, Morris, Timothy, Brocklehurst, Peter, Carr, Robert, Cowan, Frances, Patel, Nishma, Petrou, Stavros, Redshaw, Margaret, Modi, Neena, Doré, Caroline J
Publicado no Arch Dis Child Fetal Neonatal Ed (2015)

Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial

Por Cummins, Sharon, Zhu, Shu-Hong, Gamst, Anthony, Kirby, Carrie, Brandstein, Kendra, Klonoff-Cohen, Hillary, Chaplin, Edward, Morris, Timothy, Seymann, Gregory, Lee, Joshua
Publicado em 2012

A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years

Por Marlow, Neil, Morris, Timothy, Brocklehurst, Peter, Carr, Robert, Cowan, Frances M, Patel, Nishma, Petrou, Stavros, Redshaw, Maggie E, Modi, Neena, Dore, Caroline
Publicado em 2013